As of November, 2019, the KDA has awarded $1,495,250 in research grants to help find a cure or treatment for Kennedy's Disease.  To see all of the research grants funded, click here.

2020 Research Grant Propoosal Announcement

The Kennedy's Disease Association (KDA) is planning to fund one or more research grants this fall to further the understanding of the pathological mechanisms of Kennedy's Disease. The KDA projects that funding for each grant will be up to $50,000. Applications from junior investigators and from senior post-doctoral fellows are encouraged. Your proposals must be received by Friday, December 18, 2020. The KDA will send a confirmation email within three days of receipt. For more information with deadlines, click here.  


Because the KDA is relatively small and funding is limited, our focus in recent years has been to provide “seed-money” to post-doc and other young researchers who do not currently have the funding or credentials to receive funding from larger organizations such as the National Institute of Health or the MDA. This “seed-money” normally provides the researcher an opportunity to further his/her research while giving him/her time to apply for other grants


In recent years, the awarding process takes place in the fall. In the late summer, the KDA announces to all known Kennedy’s Disease Researchers that anyone interested should send in their grant requests as outlined in the proposal notification.  The Scientific Review Board reviews all applications with a focus on research projects that are specific to or could be used in finding a treatment or cure for Kennedy’s Disease.  The Scientific Review Board recommends to the Board of Directors which applicant(s) should receive research funding.  The Board of Directors notifies all candidates and awards the grants normally in October.

"I received a pilot grant from the KDA early in my career at a particularly vulnerable time for young scientists, before receiving my first grant from the NIH. The foundation's support made a big impact, helping enable us to generate a mouse model that we continue to study to understand disease mechanisms and therapeutic targets."

Andrew Lieberman, MD PhD
University of Michigan Medical School

Grant Recipients Previous Grant Reciepients